IL6 and pulmonary fibrosis: MSCs modulate inflammation and alleviate pulmonary fibrosis caused by bleomycin (mouse model) through reducing lung fibrosis and preventing pulmonary malfunction by lowering secretion of TNF-α, IFN-γ, MCP-1 and IL-6 in lungs.